when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News

Hubs

Topics
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

ROCHE · news · pharmadog

← back to ROCHE

News mentioning ROCHE

106 stories

May 8, 26Post–T-DXd Sacituzumab Govitecan Plus Trastuzumab Yields Low ORR in HER2+ Metastatic Breast Canceronclive

May 8, 26Capivasertib/Fulvestrant Yields Numerical OS Advantage in PIK3CA/AKT1/PTEN–Altered Breast Canceronclive

May 8, 26Spain readies for evacuations as a hantavirus-hit cruise ship heads for the Canary Islandsstat

May 8, 26STAT+: Roche to buy PathAI for $750 millionstat

May 8, 26Lilly to invest extra $4.5B across Indiana manufacturingbiopharma dive

May 7, 26Entrada stock falls on Duchenne data; Wegovy expands accessendpoints

May 7, 26Roche to acquire digital pathology firm PathAI in deal potentially worth over $1Bbiopharma dive

May 6, 26Cases and Conversations™: Next-Generation Pathology Advances and Considerations for Precision Care in Non–Small Cell Lung Canceronclive

May 6, 26Bayer to buy Perfuse for up to $2.45B, bolstering eye drug pipelinebiopharma dive

May 4, 26Celcuity strengthens case for ASCO-spotlighted breast cancer drugbiopharma dive

May 1, 26Arvinas’ ‘Protac’ breast cancer drug cleared by FDAbiopharma dive

Apr 30, 26Avalyn, in pursuit of better lung drugs, banks $300M in an IPObiopharma dive

Apr 28, 26Biotech investors gamble on M&A. Some drugmakers are betting on themselves instead.biopharma dive

Apr 27, 26STAT+: Pharmalittle: We’re reading about a Lilly deal, an Intellia CRISPR rare-disease treatment, and morestat

Dec 23, 25Fierce Biotech Layoff Tracker 2026: Kolon cuts workforce after ph. 3 fail; Sanofi sheds 229 staffersfiercebiotech

Dec 22, 25Fierce Biotech Fundraising Tracker '26: Abcuro secures $66M; InduPro assembles $77Mfiercebiotech

← prevpage 4 of 4next →